inclusion criteria: positive sars-cov-2 diagnostic test (rt-pcr or validated rapid antigen test) ≤72 hours prior to randomization at least three of the following symptoms of at least moderate (score ≥2 as per covid-19 symptom diary) intensity: nasal congestion or runny nose, sore throat, cough, shortness of breath, muscle or body aches, fatigue, headache, chills or sweats, feeling hot or feverish, nausea, vomiting, or diarrhea. has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days before dosing on day 1

inclusion criteria: positive sars-cov-2 diagnostic test (rt-pcr or validated rapid antigen test) ≤72 hours prior to randomization at least three of the following symptoms of at least moderate (score ≥2 as per covid-19 symptom diary) intensity: nasal congestion or runny nose, sore throat, cough, shortness of breath, muscle or body aches, fatigue, headache, chills or sweats, feeling hot or feverish, nausea, vomiting, or diarrhea. has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days before dosing on day 1